# Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Source: https://onco.cc/trials/nct00602082/  
OnCo record `nct00602082` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Capecitabine, Cisplatin and Streptozocin in Pancreatic neuroendocrine tumours, run by Cambridge University Hospitals NHS Foundation Trust, completed.

## Summary

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors is a phase 2 interventional study registered as NCT00602082 by Cambridge University Hospitals NHS Foundation Trust, with 84 participants recorded, started 2005-08 and reaching its primary completion in 2009-12. Interventions recorded: capecitabine, cisplatin, streptozocin, DNA analysis, RNA analysis, protein analysis, proteomic profiling, laboratory biomarker analysis. Conditions recorded: Gastrointestinal Carcinoid Tumor, Islet Cell Tumor.

Linked to the drug Streptozocin because the registry names it among its interventions and Pancreatic neuroendocrine tumours among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00602082
- Phase: 2
- Setting: A Randomised Phase II Study Comparing Capecitabine Plus Streptozocin With or Without Cisplatin Chemotherapy as Treatment for Unresectable or Metastatic Neuroendocrine Tumors
- Sponsor: Cambridge University Hospitals NHS Foundation Trust
- Enrolled: 84

## Sources

- ClinicalTrials.gov NCT00602082: https://clinicaltrials.gov/study/NCT00602082

## Connected records

- cancers: [Pancreatic neuroendocrine tumours](https://onco.cc/cancers/pancreatic-net/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Streptozocin](https://onco.cc/drugs/streptozocin/)

---
JSON: https://onco.cc/api/v1/entities/nct00602082.json